idw - Informationsdienst
Wissenschaft
11/30/2010 - 11/30/2010 | Heidelberg
Professor Dr. Klaus Herfarth (Department of Radiation Oncology
University Hospital Heidelberg):Locoregional treatment of prostate cancer
Priv.-Doz. Dr. Boris Hadaschik (Department of Urology
University Hospital Heidelberg): Focal therapy for prostate cancer: ready for primetime?
Dr. Dogu Teber Renal (Department of Urology
University Hospital Heidelberg): cell cancer: current status of focal therapy
Priv.-Doz. Dr. Stephanie Combs (Department of Radiation Oncology
University Hospital Heidelberg): The brain in the focus
Professor Dr. Jürgen Weitz (Department of Surgery
University Hospital Heidelberg): Local versus systemic control in surgical oncology
Maurice Stephan Michel is Professor of
Urology and Head of the Department of
Urology of the University of Mannheim.
His scientific interests are related to the
improvement and development of surgical
technology for genitourinary malignancies.
Jürgen Debus is Professor of Radiooncology
and Head of the Department of Radiooncology
and Radiation Therapy of the University of
Heidelberg. The Department of Radiation
Oncology and Radiation Therapy is among
the world‘s most advanced centers for
radiation therapy offering because the entire
spectrum of radio-oncological diagnosis and
therapy. His main focus is the improvement
of radiation technologies with the ultimate
goal to target more precisely and effectively
the tumor while reducing the toxicity of the
therapy. In this context, the Heidelberg Ion
Beam Therapy Center HIT was added to the
technological repertoire of the Department.
Jürgen Weitz is Professor of Surgery and Vice
Chairman of the Department of General-,
Visceral- and Transplantation Surgery. He is
head of the division of Surgical Oncology,
the scientific working group of Molecular
Oncology and the Clinical Research Group:
Colorectal Cancer: From primary tumor
progression towards metastasis (KFO 227).
His basic interest relates to surgical advances
for the treatment of complex and advanced
tumors.
Sascha Pahernik is Associate Professor and
Vice Chairman of the Department of Urology
of the University of Heidelberg. His main
focus of research is urooncology, in particular
minimal invasive options for the treatment of
renal cell cancer and prostate cancer.
Information on participating / attending:
Please register by 29th November
at the latest.
For this event, two points for
continuing education will be given
by the Landesärztekammer and
two AIO-Punkte will be given by
Arbeitsgemeinschaft
Internistische
Onkologie.
Within the practical year, the points
will be recognized in the field of
internal medicine and surgery.
Information and registration:
Dr. Ingrid Schamal
Fortbildungs- und Veranstaltungsorganisation
des Nationalen Centrums
für Tumorerkrankungen
Heidelberg School of Oncology
Im Neuenheimer Feld 460
69120 Heidelberg
Phone +49 (0)6221.566558
Fax +49 (0)6221.565094
ingrid.schamal@nct-heidelberg.de
Date:
11/30/2010 16:00 - 11/30/2010 18:00
Registration deadline:
11/29/2010
Event venue:
DKFZ German Cancer Reasearch Center
Im Neuenheimer Feld 280
Lecture Hall
69120 Heidelberg
69120 Heidelberg
Baden-Württemberg
Germany
Target group:
Scientists and scholars, Students
Email address:
Relevance:
local
Subject areas:
Medicine
Types of events:
Entry:
11/11/2010
Sender/author:
Alenka Tschischka
Department:
Unternehmenskommunikation
Event is free:
no
Language of the text:
English
URL of this event: http://idw-online.de/en/event33309
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).